🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseDe novo lipogenesis reduction on GLP-1 — my results so far Page 3

De novo lipogenesis reduction on GLP-1 — my results so far

DadBodDave Wed, May 22, 2024 at 6:42 PM 14 replies 2,052 viewsPage 3 of 3
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
May 22, 2024 at 10:57 PM#11
BethLabQueen said:
De novo lipogenesis reduction on is not that straightforward in my experience

This is exactly right. BethLabQueen articulated what I have been trying to explain to my friends for months. The De novo lipogenesis aspect is what made the difference for me.

3 3SarahChen_PharmD, sarah.morrison, NeuroNate
Reply Quote Save Share Report
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
May 22, 2024 at 11:14 PM#12

Reading this thread on De novo lipogenesis hits close to home. Dad of 2 checking in — I started at 293 lbs and felt like I would tried everything.

9 months on tirz and I am a different person. Not just the 68 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about De novo lipogenesis — take the leap. It was the best health decision I have ever made. ❤️

3 20Dr.RheumBOS, greg_boulder, quinn_sf
Reply Quote Save Share Report
CanadaChris
Member
234
890
Nov 2024
Toronto, CA
May 22, 2024 at 11:31 PM#13

Dr.DermMIA — that is really helpful context on De novo lipogenesis. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

Last edited: May 23, 2024 at 5:31 AM
24 1maya_sedona, stefan_berlin, Dr.EM_Chicago and 21 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
May 22, 2024 at 11:48 PM#14

To answer kevin_tulsa's question specifically:

From a clinical standpoint, De novo lipogenesis reduction is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

14 7oliver_london, tane_welly, Dr.PathRoch and 11 others
Reply Quote Save Share Report
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
May 23, 2024 at 12:05 AM#15

Bookmarked 📌 The De novo lipogenesis info in this thread is essential. Coming back to this for sure.

47 15adam_van, Dr.SurgeonPGH, rachel_ABQ and 44 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register